Headache and Pain in Guillain-Barré Syndrome

Constantine Farmakidis, Seniha Inan, Mark J. Milstein, Steven Herskovitz

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

While moderate and severe back or extremity pain is frequent in Guillain-Barré syndrome (GBS), headache appears to be uncommon. Most of the reports of headache in GBS place it in the context of the posterior reversible encephalopathy syndrome (PRES) which is increasingly recognized as a likely dysautonomia-related GBS complication. There are also a few reports of headache in the setting of increased CSF pressure and papilledema and in association with the Miller Fisher GBS variant. In comparison, back and extremity pain is highly prevalent. Aching muscle pain and neuropathic pain are the two most common of several pain types. Pain may be a heralding feature and has been described in patients as long as 2 years after disease onset. Pain management is a major axis of treatment in GBS. Gabapentin is a reasonable first-line choice, and opioid medications can be added for more severe pain but there are few clinical trials to inform specific recommendations. While the understanding of pain pathophysiology in GBS is incomplete, its prevalence and clinical impact are increasingly recognized and studied. Pain should be considered a cardinal manifestation of GBS along with acute, mostly symmetric weakness and diminished reflexes.

Original languageEnglish (US)
Article number40
JournalCurrent Pain and Headache Reports
Volume19
Issue number8
DOIs
StatePublished - Aug 1 2015

Fingerprint

Headache
Pain
Extremities
Primary Dysautonomias
Posterior Leukoencephalopathy Syndrome
Papilledema
Headache Disorders
Myalgia
Neuralgia
Pain Management
Back Pain
Opioid Analgesics
Reflex
Clinical Trials
Pressure

Keywords

  • Back pain
  • Dysautonomia
  • Guillain-Barré syndrome (GBS)
  • Headache
  • Pain
  • Posterior reversible encephalopathy syndrome

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Headache and Pain in Guillain-Barré Syndrome. / Farmakidis, Constantine; Inan, Seniha; Milstein, Mark J.; Herskovitz, Steven.

In: Current Pain and Headache Reports, Vol. 19, No. 8, 40, 01.08.2015.

Research output: Contribution to journalArticle

@article{6b1a1f3fdb1c4b08b73c91d11204cd65,
title = "Headache and Pain in Guillain-Barr{\'e} Syndrome",
abstract = "While moderate and severe back or extremity pain is frequent in Guillain-Barr{\'e} syndrome (GBS), headache appears to be uncommon. Most of the reports of headache in GBS place it in the context of the posterior reversible encephalopathy syndrome (PRES) which is increasingly recognized as a likely dysautonomia-related GBS complication. There are also a few reports of headache in the setting of increased CSF pressure and papilledema and in association with the Miller Fisher GBS variant. In comparison, back and extremity pain is highly prevalent. Aching muscle pain and neuropathic pain are the two most common of several pain types. Pain may be a heralding feature and has been described in patients as long as 2 years after disease onset. Pain management is a major axis of treatment in GBS. Gabapentin is a reasonable first-line choice, and opioid medications can be added for more severe pain but there are few clinical trials to inform specific recommendations. While the understanding of pain pathophysiology in GBS is incomplete, its prevalence and clinical impact are increasingly recognized and studied. Pain should be considered a cardinal manifestation of GBS along with acute, mostly symmetric weakness and diminished reflexes.",
keywords = "Back pain, Dysautonomia, Guillain-Barr{\'e} syndrome (GBS), Headache, Pain, Posterior reversible encephalopathy syndrome",
author = "Constantine Farmakidis and Seniha Inan and Milstein, {Mark J.} and Steven Herskovitz",
year = "2015",
month = "8",
day = "1",
doi = "10.1007/s11916-015-0508-x",
language = "English (US)",
volume = "19",
journal = "Current Pain and Headache Reports",
issn = "1531-3433",
publisher = "Current Science, Inc.",
number = "8",

}

TY - JOUR

T1 - Headache and Pain in Guillain-Barré Syndrome

AU - Farmakidis, Constantine

AU - Inan, Seniha

AU - Milstein, Mark J.

AU - Herskovitz, Steven

PY - 2015/8/1

Y1 - 2015/8/1

N2 - While moderate and severe back or extremity pain is frequent in Guillain-Barré syndrome (GBS), headache appears to be uncommon. Most of the reports of headache in GBS place it in the context of the posterior reversible encephalopathy syndrome (PRES) which is increasingly recognized as a likely dysautonomia-related GBS complication. There are also a few reports of headache in the setting of increased CSF pressure and papilledema and in association with the Miller Fisher GBS variant. In comparison, back and extremity pain is highly prevalent. Aching muscle pain and neuropathic pain are the two most common of several pain types. Pain may be a heralding feature and has been described in patients as long as 2 years after disease onset. Pain management is a major axis of treatment in GBS. Gabapentin is a reasonable first-line choice, and opioid medications can be added for more severe pain but there are few clinical trials to inform specific recommendations. While the understanding of pain pathophysiology in GBS is incomplete, its prevalence and clinical impact are increasingly recognized and studied. Pain should be considered a cardinal manifestation of GBS along with acute, mostly symmetric weakness and diminished reflexes.

AB - While moderate and severe back or extremity pain is frequent in Guillain-Barré syndrome (GBS), headache appears to be uncommon. Most of the reports of headache in GBS place it in the context of the posterior reversible encephalopathy syndrome (PRES) which is increasingly recognized as a likely dysautonomia-related GBS complication. There are also a few reports of headache in the setting of increased CSF pressure and papilledema and in association with the Miller Fisher GBS variant. In comparison, back and extremity pain is highly prevalent. Aching muscle pain and neuropathic pain are the two most common of several pain types. Pain may be a heralding feature and has been described in patients as long as 2 years after disease onset. Pain management is a major axis of treatment in GBS. Gabapentin is a reasonable first-line choice, and opioid medications can be added for more severe pain but there are few clinical trials to inform specific recommendations. While the understanding of pain pathophysiology in GBS is incomplete, its prevalence and clinical impact are increasingly recognized and studied. Pain should be considered a cardinal manifestation of GBS along with acute, mostly symmetric weakness and diminished reflexes.

KW - Back pain

KW - Dysautonomia

KW - Guillain-Barré syndrome (GBS)

KW - Headache

KW - Pain

KW - Posterior reversible encephalopathy syndrome

UR - http://www.scopus.com/inward/record.url?scp=84933527429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933527429&partnerID=8YFLogxK

U2 - 10.1007/s11916-015-0508-x

DO - 10.1007/s11916-015-0508-x

M3 - Article

C2 - 26122532

AN - SCOPUS:84933527429

VL - 19

JO - Current Pain and Headache Reports

JF - Current Pain and Headache Reports

SN - 1531-3433

IS - 8

M1 - 40

ER -